UN OWG Proposed Target 3.8
RATING: For UHC the rating is PHENOMENAL, assuming a gradual increase in coverage over time, focusing first on diseases where interventions have high benefits-to-costs. For financial risk protection the rating is UNCERTAIN. For affordable essential medicines, since much depends on what is meant by “affordable” and “essential”, the rating is UNCERTAIN. The cost structure of vaccines is typically cheaper with known benefits. The rating for these is therefore, GOOD.
Download the entire report
In our recent report, not just the target above, but all 169 targets have been assessed by 60 teams of the world’s top economists. The targets have been categorized into five ratings based on evidence of economic, social, and environmental costs and benefits. While we applaud that the UN Open Working Group's final outcome document contains 43 fewer targets than the previous document, we are concerned that many targets have simply been combined, therefore reducing the number of both phenomenal and poor targets assessed according to our cost-benefit analysis. Our new assessment includes suggestions for how these can be improved as reported in this article by the Financial Times.
